Healthcare -
Biotechnology - NASDAQ - US
$ 15.5
-6.4 %
$ 2.25 B
Market Cap
-6.03
P/E
DNLI - OTHER CURRENT LIABILITIES
Other Current Liabilities DNLI - Denali Therapeutics Inc.
61.2 M
LAST VALUE
13.29%
2 YEAR CAGR
25.76%
5 YEAR CAGR
0.00%
10 YEAR CAGR